Citius Oncology, Inc. (CTOR) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Citius Oncology, Inc. (CTOR) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $82.7M, listed on NASDAQ, employing roughly 285 people, carrying a beta of 3.58 to the broader market. Citius Oncology, Inc. Led by Leonard L. Mazur, public since 2022-12-08.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for CTOR as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →